Birmingham, February 11, 2022 – Alveolus Bio announced today Dr. Vivek Lal, Founder & Chief Executive Officer, will be presenting at the upcoming 2022 BIO CEO & Investor Conference being held at the Marriott Marquis in NYC on February 14-15 and virtually through the 17th.

Hosted annually by the Biotechnology Innovation Organization (BIO) for over 20 years, the conference is focused on emerging public and private companies, offering a meeting place for institutional investors, industry analysts, and senior biotech executives. The conference draws biotech companies looking to make the connections needed to take their products to the next phase.


Alveolus Bio is an emerging leader in the development of breakthrough biotherapeutics for respiratory disease. The company has built a strong pipeline of live biotherapeutics for chronic lung diseases, leveraging its proprietary resMIT® technology to develop inhaled microbiota-based therapies to target imbalances in the lung microbiome associated with inflammatory pulmonary disease. Currently, Alveolus Bio has pre-clinical programs targeting COPD, IPF, and neutrophilic asthma.


About Alveolus Bio

Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for chronic lung diseases. The Alveolus pipeline includes preclinical phase biotherapeutics for Chronic Obstructive Pulmonary Disease (COPD), and Idiopathic Pulmonary Fibrosis (IPF), Neutrophilic Asthma, and Pulmonary Arterial Hypertension (PAH).


About BIO
BIO is the world’s largest advocacy organization representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. Subscribe to Good Day BIO.

Media Contact:
Maggie Belshe
[email protected]
(415) 302-9240